Cargando…

Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma

BACKGROUND: The guanine nucleotide-binding protein, alpha stimulating (GNAS) gene has been associated with growth hormone (GH)-secreting pituitary adenoma. We investigated the prevalence of GNAS mutations in Korean patients with acromegaly and assessed whether mutation status correlated with biochem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Hyein, Kim, Kyungwon, Kim, Daham, Moon, Ju Hyung, Kim, Eui Hyun, Kim, Se Hoon, Ku, Cheol Ryong, Lee, Eun Jig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090461/ https://www.ncbi.nlm.nih.gov/pubmed/33752302 http://dx.doi.org/10.3803/EnM.2020.875

Ejemplares similares

Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant
por: Ku, Cheol Ryong, et al.
Publicado: (2021)

MON-436 Clinical Phenotypes of GNAS Gene Mutations in Acromegalic Patients
por: Jung, Hyein, et al.
Publicado: (2019)

Dexamethasone suppression for (18)F-FDG PET/CT to localize ACTH-secreting pituitary tumors
por: Kim, Kyungwon, et al.
Publicado: (2023)

Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
por: Kim, Daham, et al.
Publicado: (2019)

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
por: Kim, Jean, et al.
Publicado: (2020)

MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal
por: Kim, Kyungwon, et al.
Publicado: (2019)

SAT-436 Adjuvant Therapeutic Modalities in Acromegaly: Clinical Course and Factors Predicting Biochemical Controls
por: Jung, Hyein, et al.
Publicado: (2019)

Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience
por: Hong, Seung Woo, et al.
Publicado: (2021)

Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
por: Kim, Junhyung, et al.
Publicado: (2019)

Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Adrenocorticotropic Hormone-Secreting Esthesioneuroblastoma with Ectopic Cushing's Syndrome
por: Chung, Young Soo, et al.
Publicado: (2020)

Gigantism caused by growth hormone secreting pituitary adenoma
por: Rhee, Noorisaem, et al.
Publicado: (2014)

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
por: Kim, Kyungwon, et al.
Publicado: (2023)

Thyroid-Stimulating Hormone-Secreting Pituitary Adenomas : Single Institutional Experience of 14 Consecutive Cases
por: Byun, Joonho, et al.
Publicado: (2020)

SUN-446 Association between Prolactin Level and Tumor Size Reduction at 3 Months after Cabergoline Treatment in Patients with Macroprolactinoma
por: Kim, Daham, et al.
Publicado: (2019)

Antidiabetic Effects of NRDT50, the Enzyme Composition for Regulating Sugar Metabolism, in Db/db Mice
por: Kim, Daham, et al.
Publicado: (2021)

THU553 Anti-tumor Effect Of Rosiglitazone Via Upregulating 15-PDGH In Prolactin Secreting Adenoma
por: Kang, Chan Woo, et al.
Publicado: (2023)

Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
por: Ku, Cheol Ryong, et al.
Publicado: (2020)

Acetate-Mediated Odorant Receptor OR51E2 Activation Results in Calcitonin Secretion in Parafollicular C-Cells: A Novel Diagnostic Target of Human Medullary Thyroid Cancer
por: Lee, Hyeon Jeong, et al.
Publicado: (2023)

Surgical Treatment of Prolactinomas: Potential Role as a First-Line Treatment Modality
por: Kim, Eui Hyun, et al.
Publicado: (2023)

Long-term outcomes of surgery and radiotherapy for secreting and non-secreting pituitary adenoma
por: Kim, Mi Young, et al.
Publicado: (2016)

Investigation of Responsiveness to Thyrotropin-Releasing Hormone in Growth Hormone-Producing Pituitary Adenomas
por: Chin, Sang Ouk, et al.
Publicado: (2013)

Long-acting recombinant human follicle-stimulating hormone (SAFA-FSH) enhances spermatogenesis
por: Kim, Daham, et al.
Publicado: (2023)

FRI533 A Novel Cre-loxP Based Mouse Model For Graves' Disease
por: Kim, Daham, et al.
Publicado: (2023)

Potential of an Enzyme Mixture of Glucose Oxidase, Glucosyl Transferase, and Fructosyl Transferase as an Antidiabetic Medicine
por: Kim, Daham, et al.
Publicado: (2021)

No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study)
por: Ku, Cheol Ryong, et al.
Publicado: (2016)

Propofol Requirement in Patients with Growth Hormone-Secreting Pituitary Tumors Undergoing Transsphenoidal Surgery
por: Kim, Seung Hyun, et al.
Publicado: (2019)

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas
por: Wang, Ji-wen, et al.
Publicado: (2014)

In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells
por: Cuny, Thomas, et al.
Publicado: (2016)

Follicle-stimulating Hormone-secreting Pituitary Adenoma Accompanied by Painful Thyroiditis
por: Ichijo, Masashi, et al.
Publicado: (2019)

SAT-276 Co-Secreting TSH and Growth Hormone Pituitary Adenoma
por: Eid, Hatem
Publicado: (2020)

Adrenocorticotropic Hormone-Independent Cushing Syndrome with Bilateral Cortisol-Secreting Adenomas
por: Ku, Eu Jeong, et al.
Publicado: (2013)

Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma
por: Kim, Hae-Kyung, et al.
Publicado: (2021)

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
por: Lee, Youngki, et al.
Publicado: (2014)

Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma
por: Wang, Meng, et al.
Publicado: (2022)

Use of long non-coding RNAs for the molecular diagnosis of papillary thyroid cancer
por: Kim, Daham, et al.
Publicado: (2022)

Olfactory marker protein regulation of glucagon secretion in hyperglycemia
por: Oh, Ju Hun, et al.
Publicado: (2022)

Transformation of a Microprolactinoma into a Mixed Growth Hormone and Prolactin-Secreting Pituitary Adenoma
por: Dessimoz, Cédric, et al.
Publicado: (2012)

Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells
por: An, Jiayin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_asm07rqsq7bj7kq4qo9u0iqdoc